Non-Insulin-Dependent Diabetes Mellitus disease length
Item
type 2 diabetes for at least 24 months
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Body mass index
Item
bmi between 18 and 30 kg/m2
boolean
C1305855 (UMLS CUI [1])
Insulin Therapy naive
Item
insulin naive subjects
boolean
C0021641 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
Oral hypoglycemic Quantity | Combined Modality Therapy
Item
oad treatment with max two oads alone or combined with other therapy
boolean
C0359086 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0009429 (UMLS CUI [2])
Glycosylated hemoglobin A
Item
hba1c between 7-12%
boolean
C0019018 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Investigational New Drugs
Item
receipt of any investigational drug within the last three months prior to this trial
boolean
C0013230 (UMLS CUI [1])
Thiazolidinediones
Item
current or previous treatment with thiazolidiones within the last 6 months
boolean
C1257987 (UMLS CUI [1])
Oral hypoglycemic Quantity
Item
oad treatment with three or more oads within the last 4 months
boolean
C0359086 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])